Alan Kozikowski
Keine laufenden Positionen mehr
Vermögen: 436 545 $ am 30.04.2024
Profil
Alan P.
Kozikowski was the founder of Actuate Therapeutics, Inc. (founded in 2015) and Bright Minds Biosciences, Inc. (founded in 2019), where he held the title of Director in 2022.
He was the President & Chief Executive Officer of Starwise Therapeutics LLC from 2017 to 2020.
He also held the title of Director-Drug Discovery Program at Georgetown University Medical Center and was a Professor at the University of Pittsburgh.
From 2013 to 2017, he was a Professor-Emeritus at the University of Illinois.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.12.2023 | 400 500 ( 9,27% ) | 436 545 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Alan Kozikowski
| Unternehmen | Position | Ende |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Gründer | 07.09.2022 |
| Starwise Therapeutics LLC | Vorstandsvorsitzender | 01.02.2020 |
| University of Illinois | Corporate Officer/Principal | 31.07.2017 |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. operates as a private biopharmaceutical company. It offers treatment for cancer and inflammatory diseases. The company was founded by Andrew P. Mazar in 2015 and is headquartered in Fort Worth, TX. | Gründer | - |
| Georgetown University Medical Center | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Starwise Therapeutics LLC | |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. operates as a private biopharmaceutical company. It offers treatment for cancer and inflammatory diseases. The company was founded by Andrew P. Mazar in 2015 and is headquartered in Fort Worth, TX. | Health Technology |
